Renaissance Technologies (RenTech)'s AVXL Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 276,800 shares of Anavex Life Sciences Corp. (AVXL) worth $849,776, representing 0.00% of the portfolio. First purchased in 2018-Q4, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in AVXL, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 386,537 shares. Largest reduction occurred in Q2 2020, reducing 407,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Anavex Life Sciences (AVXL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Anavex Life Sciences (AVXL) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +251,378 | Add 988.82% | 276,800 | $3.07 |
| Q4 2025 | +25,422 | New Buy | 25,422 | $3.56 |
| Q2 2025 | -14,000 | Sold Out | 0 | $0.00 |
| Q1 2025 | -199,200 | Reduce 93.43% | 14,000 | $8.58 |
| Q4 2024 | -30,600 | Reduce 12.55% | 213,200 | $10.74 |
| Q3 2024 | -222,637 | Reduce 47.73% | 243,800 | $5.68 |
| Q2 2024 | +386,537 | Add 483.78% | 466,437 | $4.22 |
| Q1 2024 | +79,900 | New Buy | 79,900 | $5.09 |
| Q4 2022 | -367,100 | Sold Out | 0 | $0.00 |
| Q3 2022 | +9,300 | Add 2.60% | 367,100 | $10.32 |
| Q2 2022 | +357,800 | New Buy | 357,800 | $10.01 |
| Q1 2021 | -63,100 | Sold Out | 0 | $0.00 |
| Q4 2020 | +63,100 | New Buy | 63,100 | $5.40 |
| Q2 2020 | -407,400 | Sold Out | 0 | $0.00 |
| Q1 2020 | +325,859 | Add 399.63% | 407,400 | $3.15 |
| Q4 2019 | +81,541 | New Buy | 81,541 | $2.59 |
| Q1 2019 | -18,109 | Sold Out | 0 | $0.00 |
| Q4 2018 | +18,109 | New Buy | 18,109 | $1.55 |
Renaissance Technologies (RenTech)'s Anavex Life Sciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Anavex Life Sciences Corp. (AVXL) in Q4 2018, acquiring 18,109 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Anavex Life Sciences Corp. (AVXL) for 18 quarters since Q4 2018.
Renaissance Technologies (RenTech)'s largest addition to Anavex Life Sciences Corp. (AVXL) was in Q2 2024, adding 466,437 shares worth $1.97 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 276,800 shares of Anavex Life Sciences Corp. (AVXL), valued at approximately $849,776.
As of the Q1 2026 filing, Anavex Life Sciences Corp. (AVXL) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Anavex Life Sciences Corp. (AVXL) was 466,437 shares, as reported at the end of Q2 2024.